Cooper Companies | COO - Eigenkapital Und Reserven

Aktienkurs
72.05
Täglich Wechseln
1.01 1.42%
Monatlich
-13.61%
Jährlich
-9.98%
Q1 Prognose
67.81




Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.13B 1.3B 2025-12
Align Technology USD 3.96B 44.68M 2025-09
AtriCure USD 491.94M 15.43M 2025-12
Avanos Medical USD 778.2M 200K 2025-12
Bausch Health Companies USD -554M 910M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Bayer EUR 25.95B 3.75B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Dentsply International USD 1.34B 139M 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Globus Medical USD 4.57B 174.42M 2025-12
Haemonetics USD 911.45M 62.28M 2025-12
Hologic USD 5.25B 197.2M 2025-12
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
J&J USD 78.47B 0 2025-09
Medtronic USD 48.86B 964M 2025-09
Merit Medical Systems USD 1.58B 54.9M 2025-12
Novartis USD 44.33B 2.28B 2025-09
ResMed USD 6.32B 199.61M 2025-12
STAAR Surgical USD 344.18M 9.6M 2025-12
Steris USD 7.15B 145.4M 2025-12
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Utah Medical Products USD 118.25M 719K 2025-09
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12